Supurva Healthcare Group Stock Gross Profit
| SPRV Stock | USD 0.0001 0.0001 50.00% |
Supurva Healthcare Group fundamentals help investors to digest information that contributes to Supurva Healthcare's financial success or failures. It also enables traders to predict the movement of Supurva Pink Sheet. The fundamental analysis module provides a way to measure Supurva Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Supurva Healthcare pink sheet.
Supurva |
Supurva Healthcare Group Company Gross Profit Analysis
Supurva Healthcare's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, Supurva Healthcare Group reported 0.0 of gross profit. This is 100.0% lower than that of the Financial Services sector and about the same as Shell Companies (which currently averages 0.0) industry. The gross profit for all United States stocks is 100.0% higher than that of the company.
Supurva Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Supurva Healthcare's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Supurva Healthcare could also be used in its relative valuation, which is a method of valuing Supurva Healthcare by comparing valuation metrics of similar companies.Supurva Healthcare is currently under evaluation in gross profit category among its peers.
Supurva Fundamentals
| Net Income | (304.78 K) | |||
| Total Debt | 740.83 K | |||
| Cash Flow From Operations | (329.58 K) | |||
| Beta | 28.84 | |||
| Total Asset | 6.81 K | |||
| Net Asset | 6.81 K |
About Supurva Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Supurva Healthcare Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Supurva Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Supurva Healthcare Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Supurva Pink Sheet Analysis
When running Supurva Healthcare's price analysis, check to measure Supurva Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Supurva Healthcare is operating at the current time. Most of Supurva Healthcare's value examination focuses on studying past and present price action to predict the probability of Supurva Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Supurva Healthcare's price. Additionally, you may evaluate how the addition of Supurva Healthcare to your portfolios can decrease your overall portfolio volatility.